Contributors
Joseph Abdelmalak, Robin K. Avery(Johns Hopkins University), Talal Adhami, Andrew Boyle(University of Miami), John R. Bartholomew(University of Rochester Medical Center), Deepak L. Bhatt(Mount Sinai Hospital), John C. Carey(University of Utah Health Care), Sheila Armogida, Joseph Austerman, Pelin Batur, David Barnes(University of Southern Mississippi), Ahmed Absi, David J. Adelstein(Cleveland Clinic), Arman T. Askari, Laura K. Bianchi, Marjan Attaran, Allan Boike, Federico Aucejo(Cleveland Clinic), Feyrouz Al-Ashkar, Darwin L. Caldwell, Carol A. Burke(Cleveland Clinic), Mercedes E. Arroliga, Kathleen Ashton, Kamal Adury, Amjad AlMahameed, Charles Camisa(Unknown), Michael H. Bolooki, Antoine Amado, Sorin J. Brener, Natasha Atanaskova, Wilma F. Bergfeld(Cleveland Clinic), Rachid Baz(Moffitt Cancer Center), Yvonne Braver, Wendy S. Armstrong(Emory University), Anjali S. Advani(Cleveland Clinic), Marie Budev, Matthew Bunyard, Alejandro C. Arroliga(Cleveland Clinic), William E. Braun(Cleveland Clinic), H. Nail Aydin, Swati Bharadwaj, Brian J. Bolwell(Cleveland Clinic), Linda A Bradley, Abby Abelson, Edgar Achkar, Corinne Bott‐Silverman, Stacy A. Brethauer(The Ohio State University Wexner Medical Center), Leonard H. Calabrese(Cleveland Clinic), Saud Butt
Cited by 0
Related Papers
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
|New England Journal of Medicine|2018|3.2k
A Controlled Trial of Renal Denervation for Resistant Hypertension
|New England Journal of Medicine|2014|2.2k
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
|New England Journal of Medicine|2015|2k